{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:03:12Z","timestamp":1790856192433,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.tem.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T09:16:44Z","timestamp":1536139004000},"page":"841-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1504-9734","authenticated-orcid":false,"given":"Kirsty A.","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Ledger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.","family":"Teede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2018.08.005_bib0005","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2018.08.005_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"Teede","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponosored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0030","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2018.08.005_bib0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrendo.2016.157","article-title":"PCOS: refining diagnostic features in PCOS to optimize health outcomes","volume":"12","author":"Boyle","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-0035-1571195","article-title":"Polycystic ovary syndrome, obesity, and pregnancy","volume":"34","author":"Joham","year":"2016","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.tem.2018.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/AOG.0000000000000852","article-title":"Implications of polycystic ovary syndrome for pregnancy and for the health of offspring","volume":"125","author":"Doherty","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.tem.2018.08.005_bib0050","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/imj.12495","article-title":"Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about","volume":"44","author":"Shorakae","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.tem.2018.08.005_bib0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","article-title":"Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome","volume":"47","author":"Livadas","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2018.08.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093805","article-title":"Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry","volume":"9","author":"Keefe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2018.08.005_bib0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.steroids.2014.06.005","article-title":"Lipid profile in nonobese pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"88C","author":"Palomba","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2018.08.005_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","article-title":"The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives","volume":"33","author":"Hague","year":"1990","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2018.08.005_bib0080","first-page":"702","article-title":"Polycystic ovaries in female-to-male transsexuals","volume":"39","author":"Pache","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2018.08.005_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-69-1-151","article-title":"The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects","volume":"69","author":"Spinder","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0090","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.097808","article-title":"Rodent models for human polycystic ovary syndrome","volume":"86","author":"Walters","year":"2012","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0100","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1530\/REP-14-0517","article-title":"Role of androgens in normal and pathological ovarian function","volume":"149","author":"Walters","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.tem.2018.08.005_bib0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype","volume":"373","author":"Padmanabhan","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","article-title":"Nonhuman primate models of polycystic ovary syndrome","volume":"373","author":"Abbott","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beem.2018.03.008","article-title":"Evidence from animal models on the pathogenesis of PCOS","volume":"32","author":"Walters","year":"2018","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/en.2012-1954","article-title":"Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome","volume":"154","author":"Moore","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0125","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/oby.20719","article-title":"Central mechanisms of adiposity in adult female mice with androgen excess","volume":"22","author":"Nohara","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tem.2018.08.005_bib0135","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0140","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1095\/biolreprod.115.131631","article-title":"A novel letrozole model recapitulates both the reproductive and metabolic phenotypes of polycystic ovary syndrome in female mice","volume":"93","author":"Kauffman","year":"2015","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0150","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1210\/en.2014-1050","article-title":"Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys","volume":"155","author":"Keller","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jne.12258","article-title":"Hypothalamic expression of oestrogen receptor alpha and androgen receptor is sex-, age- and region-dependent in mice","volume":"27","author":"Brock","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2014.10.028","article-title":"Sex differences in spatiotemporal expression of AR, ERalpha, and ERbeta mRNA in the perinatal mouse brain","volume":"584","author":"Mogi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tem.2018.08.005_bib0165","first-page":"47","article-title":"Role of androgens in the ovary","volume":"465","author":"Walters","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000487762","article-title":"The role of central androgen receptor actions in regulating the hypothalamic\u2013pituitary\u2013ovarian axis","volume":"106","author":"Walters","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0175","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2014-1887","article-title":"Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization","volume":"156","author":"Caldwell","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0180","doi-asserted-by":"crossref","first-page":"e001","DOI":"10.1621\/nrs.11001","article-title":"Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone\/muscle, metabolic syndrome and neuron\/immune systems: lessons learned from mice lacking AR in specific cells","volume":"11","author":"Chang","year":"2013","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.tem.2018.08.005_bib0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/09513590.2012.754876","article-title":"Ovulatory effects of flutamide in the polycystic ovary syndrome","volume":"29","author":"Paradisi","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0190","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0195","first-page":"18","article-title":"The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS","volume":"6","author":"Baculescu","year":"2013","journal-title":"J. Med. Life"},{"key":"10.1016\/j.tem.2018.08.005_bib0200","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1073\/pnas.1703436114","article-title":"Neuronal androgen receptor: molecular gateway to polycystic ovary syndrome?","volume":"114","author":"Abbott","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2012.10.010","article-title":"Adipocyte biology in polycystic ovary syndrome","volume":"373","author":"Barber","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0210","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1530\/JME-12-0247","article-title":"Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome","volume":"50","author":"Chen","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0215","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Feburary (2)","key":"10.1016\/j.tem.2018.08.005_bib0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1210\/en.2015-1565","article-title":"Developmental programming: impact of gestational steroid and metabolic milieus on adiposity and insulin sensitivity in prenatal testosterone-treated female sheep","volume":"157","author":"Cardoso","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0225","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0230","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manneras-Holm","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0235","doi-asserted-by":"crossref","first-page":"E7187","DOI":"10.1073\/pnas.1708854114","article-title":"Adiponectin protects against development of metabolic disturbances in a PCOS mouse model","volume":"114","author":"Benrick","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0240","first-page":"98","article-title":"Androgen receptor in the ovary theca cells plays a critical role in androgen-induced reproductive dysfunction","volume":"158","author":"Ma","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2017.01.043","article-title":"Selective deletion of Pten in theca-interstitial cells leads to androgen excess and ovarian dysfunction in mice","volume":"444","author":"Lan","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0250","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2015-3776","article-title":"Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese women","volume":"101","author":"Tian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2018.08.005_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2018.08.005_bib0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2018.08.005_bib0270","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2018.08.005_bib0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrendo.2015.230","article-title":"PCOS in 2015: new insights into the genetics of polycystic ovary syndrome","volume":"12","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0280","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0285","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1210\/jc.2004-2359","article-title":"Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls","volume":"90","author":"Chhabra","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0290","doi-asserted-by":"crossref","first-page":"E10216","DOI":"10.1073\/pnas.1713897114","article-title":"Definition of the hypothalamic GnRH pulse generator in mice","volume":"114","author":"Clarkson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2012.00048","article-title":"New insights into the control of pulsatile GnRH release: the role of Kiss1\/neurokinin B neurons","volume":"3","author":"Navarro","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2018.08.005_bib0300","first-page":"367","article-title":"Kisspeptin in the hypothalamus of 2 rat models of polycystic ovary syndrome","volume":"158","author":"Osuka","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.05.049","article-title":"Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS)","volume":"1467","author":"Brown","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2018.08.005_bib0310","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/en.2009-0541","article-title":"The kisspeptin\/neurokinin B\/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep","volume":"151","author":"Cheng","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0315","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/ejn.13373","article-title":"Prenatal testosterone exposure decreases colocalization of insulin receptors in kisspeptin\/neurokinin B\/dynorphin and agouti-related peptide neurons of the adult ewe","volume":"44","author":"Cernea","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tem.2018.08.005_bib0320","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/en.2016-1613","article-title":"Developmental programming: insulin aensitizer prevents the GnRH-atimulated LH hypersecretion in a sheep model of PCOS","volume":"157","author":"Cardoso","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0325","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1210\/en.2014-1609","article-title":"Prenatal testosterone treatment leads to changes in the morphology of KNDy neurons, their inputs, and projections to GnRH cells in female sheep","volume":"156","author":"Cernea","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12929-018-0452-2","article-title":"rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women","volume":"25","author":"Albalawi","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tem.2018.08.005_bib0335","article-title":"Polycystic ovary syndrome (PCOS) and kisspeptin \u2013 a Sri Lankan study","author":"Umayal","year":"2018","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.tem.2018.08.005_bib0340","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijgo.12527","article-title":"Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women","volume":"142","author":"Daghestani","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.tem.2018.08.005_bib0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-018-1609-1","article-title":"Kisspeptin and LH pulsatile temporal coupling in PCOS patients","volume":"61","author":"Katulski","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2018.08.005_bib0350","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0355","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.0308058101","article-title":"Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder","volume":"101","author":"Sullivan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0360","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/en.2010-0823","article-title":"Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood","volume":"152","author":"Roland","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0365","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1073\/pnas.1415038112","article-title":"Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome","volume":"112","author":"Moore","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2018.08.005_bib0370","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2826.2011.02145.x","article-title":"Depolarising and hyperpolarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus","volume":"23","author":"Herbison","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0375","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/humrep\/dex086","article-title":"Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome","volume":"32","author":"Kawwass","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tem.2018.08.005_bib0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2011.07.006","article-title":"A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy","volume":"97","author":"Hu","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tem.2018.08.005_bib0385","doi-asserted-by":"crossref","first-page":"99405","DOI":"10.1172\/jci.insight.99405","article-title":"Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS","volume":"3","author":"Silva","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.tem.2018.08.005_bib0390","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1523\/JNEUROSCI.2304-17.2018","article-title":"Prepubertal development of GABAergic transmission to gonadotropin-releasing hormone (GnRH) neurons and postsynaptic response are altered by prenatal androgenization","volume":"38","author":"Berg","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2018.08.005_bib0395","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1210\/en.2005-0323","article-title":"Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse","volume":"146","author":"Smith","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2018.08.005_bib0400","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tem.2018.08.005_bib0405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2826.2011.02126.x","article-title":"Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe","volume":"23","author":"Sheppard","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2018.08.005_bib0410","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1097\/00001756-200112210-00027","article-title":"Are POMC neurons targets for sex steroids in the arcuate nucleus of the rat?","volume":"12","author":"Fodor","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.tem.2018.08.005_bib0415","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2018.08.005_bib0420","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2018.08.005_bib0425","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276018301498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276018301498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:37:56Z","timestamp":1760906276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276018301498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1043276018301498"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2018.08.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733987950.793556137","asserted-by":"object"}]},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}